局所創傷治療薬市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

局所創傷治療薬市場は、2023年に26億1,000万米ドルと評価され、2024年には28億9,000万米ドルに達すると予測され、CAGR 10.99％で成長し、2030年には54億2,000万米ドルに達すると予測されています。

局所創傷治療薬は、擦り傷、裂傷、火傷、潰瘍を含む様々なタイプの創傷の治療と管理に使用される特殊な製剤です。その範囲は治癒促進、感染予防、皮膚再生促進にまで及び、急性および慢性創傷治療のニーズに対応しています。このような薬剤の必要性は、糖尿病に関連した足潰瘍の増加、事故による傷害を受けやすい世界人口の高齢化、外科手術の普及などから生じています。主な用途は病院、在宅医療、創傷専門クリニックなどで、クリーム、軟膏、ジェルなどの形態で製品が提供されています。最終用途の範囲にはヘルスケア専門家、利害関係者、患者自身が含まれ、幅広い利害関係者の関与が強調されています。

市場の洞察によると、スマートドレッシングや生物活性創傷剤の統合などの技術的進歩が、市場成長に影響力のある役割を果たしています。この成長を促進する要因としては、ヘルスケア支出の増加、高度創傷ケアに関する意識の高まり、美容外科手術の増加などが挙げられます。しかし、高度創傷治療製品に関連する高額な費用、厳しい規制当局の承認、地域による償還政策の違いなどの課題もあります。医療インフラが拡大し、アンメット・メディカル・ニーズが大きい新興市場にはビジネスチャンスがあります。また、デジタルヘルスソリューションを活用して遠隔創傷評価を行うことで、遠隔医療の動向を取り込むことができます。企業への提言としては、多機能創傷ケア製品の研究開発に戦略的に集中すること、ヘルスケアプロバイダーとの協力関係を促進すること、高成長地域での市場浸透戦略を優先することなどが挙げられます。

イノベーションと研究の軸となるのは、生分解性で非付着性の創傷被覆材の開発や、創傷治癒の効率を高めるナノ粒子などのドラッグデリバリーシステムへの投資です。市場の性質を探る上で重要なのは、競争とイノベーション主導の市場であり、個別化医療にはまだ大きな機会が残されているということです。このような力学に機敏に適応し、継続的にイノベーションに投資し、患者や医療提供者の需要に対応できる企業は、成長と競争力を維持できる可能性が高いです。

市場力学：急速に進化する局所創傷治療薬市場の主要市場インサイトを公開

局所創傷治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の急性・慢性創傷の増加
  • 交通事故や外傷の増加
  • 創傷感染に対する認識を高めるための政府イニシアチブの高まり
• 市場抑制要因
  • 抗生物質に関する懸念
• 市場機会
  • 技術的に進んだ製品の継続的なイントロダクション
  • スマート創傷ケアとデジタルヘルスの出現
• 市場の課題
  • 厳しい承認プロセス

ポーターの5つの力：局所創傷治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：局所創傷治療薬市場における外部からの影響の把握

外部マクロ環境要因は、局所創傷治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析局所創傷治療薬市場における競合情勢の把握

局所創傷治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス局所創傷治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、局所創傷治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨局所創傷治療薬市場における成功への道筋を描く

局所創傷治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 急性および慢性創傷の発生率が世界的に増加
    • 交通事故やトラウマとなる出来事の増加
    • 創傷感染に対する意識を高める政府の取り組みが増加
  • 抑制要因
    • 抗生物質に関する懸念
  • 機会
    • 技術的に高度な製品の継続的なイントロダクション
    • スマート創傷ケアとデジタルヘルスの出現
  • 課題
    • 承認のための厳格な規制プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 局所創傷治療薬市場：製品別

• クリーム
• ゲル
• スプレー

第7章 局所創傷治療薬市場：用途別

• 急性創傷
  • やけど
  • 外科的創傷および外傷
• 慢性創傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性下肢潰瘍

第8章 局所創傷治療薬市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカの局所創傷治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の局所創傷治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの局所創傷治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca PLC
• DUKAL LLC
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• Kerecis
• Medtronic PLC
• Mylan N.V.
• Molnlycke Health Care AB
• Novartis International AG
• Pfizer, Inc.
• Smith & Nephew PLC
• Swiss-American CDMO
• Teva Pharmaceutical Industries Ltd
• Themis Medicare Ltd
• Vericel Corporation

LIST OF FIGURES

• FIGURE 1. TOPICAL WOUND AGENTS MARKET RESEARCH PROCESS
• FIGURE 2. TOPICAL WOUND AGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TOPICAL WOUND AGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TOPICAL WOUND AGENTS MARKET DYNAMICS
• TABLE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY BURN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SURGICAL & TRAUMATIC WOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 43. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 44. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 70. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 71. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 75. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 76. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 161. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 162. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 181. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 182. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 186. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 187. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Topical Wound Agents Market was valued at USD 2.61 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 10.99%, to USD 5.42 billion by 2030.

Topical wound agents are specialized formulations used for the treatment and management of various types of wounds including abrasions, lacerations, burns, and ulcers. Their scope extends to accelerating healing, preventing infections, and promoting skin regeneration, addressing both acute and chronic wound care needs. The necessity for these agents arises from rising incidences of diabetes-related foot ulcers, an aging global population vulnerable to accidental injuries, and the growing prevalence of surgical procedures. Key applications span hospital settings, home care, and specialized wound clinics, offering products in forms such as creams, ointments, and gels. End-use scope involves healthcare professionals, caregivers, and patients themselves, highlighting a broad range of stakeholder engagement.

Market insights reveal that technological advancements, such as the integration of smart dressings and bioactive wound agents, are playing influential roles in market growth. Factors driving this growth include increasing healthcare expenditure, heightened awareness regarding advanced wound care, and a rise in cosmetic surgical procedures. However, the market faces challenges including high costs associated with advanced wound care products, stringent regulatory approvals, and variations in reimbursement policies across regions. Opportunities lie in emerging markets where healthcare infrastructure is expanding and unmet medical needs are considerable. Additionally, leveraging digital health solutions for remote wound assessment could tap into telemedicine trends. Recommendations for businesses include a strategic focus on R&D for multifunctional wound care products, fostering collaborations with healthcare providers, and prioritizing market penetration strategies in high-growth regions.

Innovation and research could pivot around developing biodegradable and non-adherent wound dressing materials or investing in enhanced drug delivery systems such as nanoparticles for greater efficiency in wound healing. While exploring the nature of the market, it is crucial to note that it remains competitive and innovation-driven, with significant opportunities still unexplored in personalized medicine. Companies well-positioned to adapt nimbly to these dynamics, continually investing in innovation and aligning with patient and provider demands, are more likely to sustain their growth and competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Wound Agents Market

The Topical Wound Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of acute and chronic wounds globally
  • Increasing cases of road accidents and traumatic events
  • Rising government initiatives to increase awareness on wound infections
• Market Restraints
  • Concerns pertinent to antibiotics
• Market Opportunities
  • Ongoing introduction of technologically advanced products
  • Emergence of smart wound care and digital health
• Market Challenges
  • Strict regulatory process for approval

Porter's Five Forces: A Strategic Tool for Navigating the Topical Wound Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Wound Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Wound Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Wound Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Wound Agents Market

A detailed market share analysis in the Topical Wound Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Wound Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Wound Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Wound Agents Market

A strategic analysis of the Topical Wound Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Wound Agents Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, DUKAL LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kerecis, Medtronic PLC, Mylan N.V., Molnlycke Health Care AB, Novartis International AG, Pfizer, Inc., Smith & Nephew PLC, Swiss-American CDMO, Teva Pharmaceutical Industries Ltd, Themis Medicare Ltd, and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Wound Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cream, Gel, and Spray.
• Based on Application, market is studied across Acute Wound and Chronic Wound. The Acute Wound is further studied across Burn and Surgical & Traumatic Wound. The Chronic Wound is further studied across Diabetic Foot Ulcer, Pressure Ulcer, and Venous Leg Ulcer.
• Based on End User, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of acute and chronic wounds globally
    • 5.1.1.2. Increasing cases of road accidents and traumatic events
    • 5.1.1.3. Rising government initiatives to increase awareness on wound infections
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns pertinent to antibiotics
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing introduction of technologically advanced products
    • 5.1.3.2. Emergence of smart wound care and digital health
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory process for approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Topical Wound Agents Market, by Product

• 6.1. Introduction
• 6.2. Cream
• 6.3. Gel
• 6.4. Spray

7. Topical Wound Agents Market, by Application

• 7.1. Introduction
• 7.2. Acute Wound
  • 7.2.1. Burn
  • 7.2.2. Surgical & Traumatic Wound
• 7.3. Chronic Wound
  • 7.3.1. Diabetic Foot Ulcer
  • 7.3.2. Pressure Ulcer
  • 7.3.3. Venous Leg Ulcer

8. Topical Wound Agents Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Topical Wound Agents Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Topical Wound Agents Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Topical Wound Agents Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca PLC
• 2. DUKAL LLC
• 3. Integra LifeSciences Corporation
• 4. Johnson & Johnson Services, Inc.
• 5. Kerecis
• 6. Medtronic PLC
• 7. Mylan N.V.
• 8. Molnlycke Health Care AB
• 9. Novartis International AG
• 10. Pfizer, Inc.
• 11. Smith & Nephew PLC
• 12. Swiss-American CDMO
• 13. Teva Pharmaceutical Industries Ltd
• 14. Themis Medicare Ltd
• 15. Vericel Corporation